This report studies the Breast Lesion Localization Methods market, including wire localization biopsy, radioisotope localization, magnetic tracer and other products.
麻豆原创 Analysis and Insights: Global Breast Lesion Localization Methods 麻豆原创
The global Breast Lesion Localization Methods market is projected to grow from US$ 350.2 million in 2024 to US$ 450.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
The main market for breast lesion targeting methods is North America, which accounts for about 50% of the market, followed by Europe, which accounts for more than 25%.
Major companies include C.R. Bard, Cook Medical, Somatex Medical, Argon Medical Devices, Theragenics, etc., with the top three accounting for more than 80% of the market.
Report Covers:
This report presents an overview of global market for Breast Lesion Localization Methods market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Breast Lesion Localization Methods, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Breast Lesion Localization Methods, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Breast Lesion Localization Methods revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Breast Lesion Localization Methods market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by End User, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Breast Lesion Localization Methods revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
C.R. BARD
Cook Medical
Cianna Medical
Eckert & Ziegler
Theragenics
Argon Medical Devices
SOMATEX Medical
IsoAid
Endomag
Ranfac
STERYLAB
Segment by Type
Wire Localization Biopsy
Radioisotope Localization
Magnetic Tracer
Other
Segment by End User
Women
Men
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Breast Lesion Localization Methods in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Lesion Localization Methods companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by End User and by country, revenue for each segment.
Chapter 7: Europe by Type, by End User and by country, revenue for each segment.
Chapter 8: China by Type, and by End User, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by End User and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by End User and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Breast Lesion Localization Methods revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Breast Lesion Localization Methods 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Wire Localization Biopsy
1.2.3 Radioisotope Localization
1.2.4 Magnetic Tracer
1.2.5 Other
1.3 麻豆原创 by End User
1.3.1 Global Breast Lesion Localization Methods 麻豆原创 Size Growth Rate by End User, 2019 VS 2023 VS 2030
1.3.2 Women
1.3.3 Men
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Lesion Localization Methods 麻豆原创 Perspective (2019-2030)
2.2 Global Breast Lesion Localization Methods Growth Trends by Region
2.2.1 Breast Lesion Localization Methods 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Breast Lesion Localization Methods Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Breast Lesion Localization Methods Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Breast Lesion Localization Methods 麻豆原创 Dynamics
2.3.1 Breast Lesion Localization Methods Industry Trends
2.3.2 Breast Lesion Localization Methods 麻豆原创 Drivers
2.3.3 Breast Lesion Localization Methods 麻豆原创 Challenges
2.3.4 Breast Lesion Localization Methods 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Breast Lesion Localization Methods by Players
3.1.1 Global Breast Lesion Localization Methods Revenue by Players (2019-2024)
3.1.2 Global Breast Lesion Localization Methods Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Breast Lesion Localization Methods 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Breast Lesion Localization Methods, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Breast Lesion Localization Methods 麻豆原创 Concentration Ratio
3.4.1 Global Breast Lesion Localization Methods 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Lesion Localization Methods Revenue in 2023
3.5 Global Key Players of Breast Lesion Localization Methods Head office and Area Served
3.6 Global Key Players of Breast Lesion Localization Methods, Product and Application
3.7 Global Key Players of Breast Lesion Localization Methods, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Lesion Localization Methods Breakdown Data by Type
4.1 Global Breast Lesion Localization Methods Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Breast Lesion Localization Methods Forecasted 麻豆原创 Size by Type (2025-2030)
5 Breast Lesion Localization Methods Breakdown Data by End User
5.1 Global Breast Lesion Localization Methods Historic 麻豆原创 Size by End User (2019-2024)
5.2 Global Breast Lesion Localization Methods Forecasted 麻豆原创 Size by End User (2025-2030)
6 North America
6.1 North America Breast Lesion Localization Methods 麻豆原创 Size (2019-2030)
6.2 North America Breast Lesion Localization Methods 麻豆原创 Size by Type
6.2.1 North America Breast Lesion Localization Methods 麻豆原创 Size by Type (2019-2024)
6.2.2 North America Breast Lesion Localization Methods 麻豆原创 Size by Type (2025-2030)
6.2.3 North America Breast Lesion Localization Methods 麻豆原创 Share by Type (2019-2030)
6.3 North America Breast Lesion Localization Methods 麻豆原创 Size by End User
6.3.1 North America Breast Lesion Localization Methods 麻豆原创 Size by End User (2019-2024)
6.3.2 North America Breast Lesion Localization Methods 麻豆原创 Size by End User (2025-2030)
6.3.3 North America Breast Lesion Localization Methods 麻豆原创 Share by End User (2019-2030)
6.4 North America Breast Lesion Localization Methods 麻豆原创 Size by Country
6.4.1 North America Breast Lesion Localization Methods 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Breast Lesion Localization Methods 麻豆原创 Size by Country (2019-2024)
6.4.3 North America Breast Lesion Localization Methods 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Breast Lesion Localization Methods 麻豆原创 Size (2019-2030)
7.2 Europe Breast Lesion Localization Methods 麻豆原创 Size by Type
7.2.1 Europe Breast Lesion Localization Methods 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe Breast Lesion Localization Methods 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe Breast Lesion Localization Methods 麻豆原创 Share by Type (2019-2030)
7.3 Europe Breast Lesion Localization Methods 麻豆原创 Size by End User
7.3.1 Europe Breast Lesion Localization Methods 麻豆原创 Size by End User (2019-2024)
7.3.2 Europe Breast Lesion Localization Methods 麻豆原创 Size by End User (2025-2030)
7.3.3 Europe Breast Lesion Localization Methods 麻豆原创 Share by End User (2019-2030)
7.4 Europe Breast Lesion Localization Methods 麻豆原创 Size by Country
7.4.1 Europe Breast Lesion Localization Methods 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Breast Lesion Localization Methods 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe Breast Lesion Localization Methods 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Breast Lesion Localization Methods 麻豆原创 Size (2019-2030)
8.2 China Breast Lesion Localization Methods 麻豆原创 Size by Type
8.2.1 China Breast Lesion Localization Methods 麻豆原创 Size by Type (2019-2024)
8.2.2 China Breast Lesion Localization Methods 麻豆原创 Size by Type (2025-2030)
8.2.3 China Breast Lesion Localization Methods 麻豆原创 Share by Type (2019-2030)
8.3 China Breast Lesion Localization Methods 麻豆原创 Size by End User
8.3.1 China Breast Lesion Localization Methods 麻豆原创 Size by End User (2019-2024)
8.3.2 China Breast Lesion Localization Methods 麻豆原创 Size by End User (2025-2030)
8.3.3 China Breast Lesion Localization Methods 麻豆原创 Share by End User (2019-2030)
9 Asia (excluding China)
9.1 Asia Breast Lesion Localization Methods 麻豆原创 Size (2019-2030)
9.2 Asia Breast Lesion Localization Methods 麻豆原创 Size by Type
9.2.1 Asia Breast Lesion Localization Methods 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia Breast Lesion Localization Methods 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia Breast Lesion Localization Methods 麻豆原创 Share by Type (2019-2030)
9.3 Asia Breast Lesion Localization Methods 麻豆原创 Size by End User
9.3.1 Asia Breast Lesion Localization Methods 麻豆原创 Size by End User (2019-2024)
9.3.2 Asia Breast Lesion Localization Methods 麻豆原创 Size by End User (2025-2030)
9.3.3 Asia Breast Lesion Localization Methods 麻豆原创 Share by End User (2019-2030)
9.4 Asia Breast Lesion Localization Methods 麻豆原创 Size by Region
9.4.1 Asia Breast Lesion Localization Methods 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Breast Lesion Localization Methods 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia Breast Lesion Localization Methods 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Size by End User
10.3.1 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Size by End User (2019-2024)
10.3.2 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Size by End User (2025-2030)
10.3.3 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Share by End User (2019-2030)
10.4 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Breast Lesion Localization Methods 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 C.R. BARD
11.1.1 C.R. BARD Company Details
11.1.2 C.R. BARD Business Overview
11.1.3 C.R. BARD Breast Lesion Localization Methods Introduction
11.1.4 C.R. BARD Revenue in Breast Lesion Localization Methods Business (2019-2024)
11.1.5 C.R. BARD Recent Developments
11.2 Cook Medical
11.2.1 Cook Medical Company Details
11.2.2 Cook Medical Business Overview
11.2.3 Cook Medical Breast Lesion Localization Methods Introduction
11.2.4 Cook Medical Revenue in Breast Lesion Localization Methods Business (2019-2024)
11.2.5 Cook Medical Recent Developments
11.3 Cianna Medical
11.3.1 Cianna Medical Company Details
11.3.2 Cianna Medical Business Overview
11.3.3 Cianna Medical Breast Lesion Localization Methods Introduction
11.3.4 Cianna Medical Revenue in Breast Lesion Localization Methods Business (2019-2024)
11.3.5 Cianna Medical Recent Developments
11.4 Eckert & Ziegler
11.4.1 Eckert & Ziegler Company Details
11.4.2 Eckert & Ziegler Business Overview
11.4.3 Eckert & Ziegler Breast Lesion Localization Methods Introduction
11.4.4 Eckert & Ziegler Revenue in Breast Lesion Localization Methods Business (2019-2024)
11.4.5 Eckert & Ziegler Recent Developments
11.5 Theragenics
11.5.1 Theragenics Company Details
11.5.2 Theragenics Business Overview
11.5.3 Theragenics Breast Lesion Localization Methods Introduction
11.5.4 Theragenics Revenue in Breast Lesion Localization Methods Business (2019-2024)
11.5.5 Theragenics Recent Developments
11.6 Argon Medical Devices
11.6.1 Argon Medical Devices Company Details
11.6.2 Argon Medical Devices Business Overview
11.6.3 Argon Medical Devices Breast Lesion Localization Methods Introduction
11.6.4 Argon Medical Devices Revenue in Breast Lesion Localization Methods Business (2019-2024)
11.6.5 Argon Medical Devices Recent Developments
11.7 SOMATEX Medical
11.7.1 SOMATEX Medical Company Details
11.7.2 SOMATEX Medical Business Overview
11.7.3 SOMATEX Medical Breast Lesion Localization Methods Introduction
11.7.4 SOMATEX Medical Revenue in Breast Lesion Localization Methods Business (2019-2024)
11.7.5 SOMATEX Medical Recent Developments
11.8 IsoAid
11.8.1 IsoAid Company Details
11.8.2 IsoAid Business Overview
11.8.3 IsoAid Breast Lesion Localization Methods Introduction
11.8.4 IsoAid Revenue in Breast Lesion Localization Methods Business (2019-2024)
11.8.5 IsoAid Recent Developments
11.9 Endomag
11.9.1 Endomag Company Details
11.9.2 Endomag Business Overview
11.9.3 Endomag Breast Lesion Localization Methods Introduction
11.9.4 Endomag Revenue in Breast Lesion Localization Methods Business (2019-2024)
11.9.5 Endomag Recent Developments
11.10 Ranfac
11.10.1 Ranfac Company Details
11.10.2 Ranfac Business Overview
11.10.3 Ranfac Breast Lesion Localization Methods Introduction
11.10.4 Ranfac Revenue in Breast Lesion Localization Methods Business (2019-2024)
11.10.5 Ranfac Recent Developments
11.11 STERYLAB
11.11.1 STERYLAB Company Details
11.11.2 STERYLAB Business Overview
11.11.3 STERYLAB Breast Lesion Localization Methods Introduction
11.11.4 STERYLAB Revenue in Breast Lesion Localization Methods Business (2019-2024)
11.11.5 STERYLAB Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
C.R. BARD
Cook Medical
Cianna Medical
Eckert & Ziegler
Theragenics
Argon Medical Devices
SOMATEX Medical
IsoAid
Endomag
Ranfac
STERYLAB
听
听
*If Applicable.
